Low-Dosage Epoetin in Maintenance Haemodialysis

This publication has 63 references indexed in Scilit:

• A Comparison of the Costs and Benefits of Recombinant Human Erythropoietin (Epoetin) in the Treatment of Chronic Renal Failure in 5 European Countries
  PharmacoEconomics, 1992
• Cost benefits of low dose subcutaneous erythropoietin in patients with anaemia of end stage renal disease.
  BMJ, 1992
• A Disease-Specific Questionnaire for Assessing Quality of Life in Patients on Hemodialysis
  Nephron, 1992
• Low dose erythropoietin in maintenance haemodialysis: improvement in quality of life and reduction in true cost of haemodialysis
  Australian and New Zealand Journal of Medicine, 1991
• Epoetin alfa in anaemic children or adolescents on regular dialysis
  European Journal of Pediatrics, 1991
• Treatment of Transfusion-Dependent Anaemia of Chronic Renal Failure with Recombinant Human Erythropoietin: A European multicentre study in 142 patients to define dose regimen and safety profile
  Nephrology Dialysis Transplantation, 1991
• Benefits and risks of anemia correction with recombinant human erythropoietin in children maintained by hemodialysis
  The Journal of Pediatrics, 1990
• The Treatment of Anemia with Low-Dose Recombinant Human Erythropoietin
  American Journal of Nephrology, 1990
• Use of subcutaneous recombinant human erythropoietin in children undergoing continuous cycling peritoneal dialysis
  The Journal of Pediatrics, 1989
• Correction of the Anemia of End-Stage Renal Disease with Recombinant Human Erythropoietin
  New England Journal of Medicine, 1987